BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8584701)

  • 1. [Gene delivery by immunogene and its application to cancer gene therapy].
    Gamou S; Chen J; Takayanagi A; Shimizu N
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2562-9. PubMed ID: 8584701
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogene approach toward cancer therapy using erythrocyte growth factor receptor-mediated gene delivery.
    Shimizu N; Chen J; Gamou S; Takayanagi A
    Cancer Gene Ther; 1996; 3(2):113-20. PubMed ID: 8729910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-mediated gene delivery using the Fab fragments of anti-epidermal growth factor receptor antibodies: improved immunogene approach.
    Chen J; Gamou S; Takayanagi A; Ohtake Y; Ohtsubo M; Shimizu N
    Cancer Gene Ther; 1998; 5(6):357-64. PubMed ID: 9917090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeting delivery of therapeutic genes using monoclonal antibody; immunogene approach].
    Takayanagi A; Chen J; Gamou S; Shimizu N
    Nihon Rinsho; 1998 Mar; 56(3):731-6. PubMed ID: 9549365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor.
    Cristiano RJ; Roth JA
    Cancer Gene Ther; 1996; 3(1):4-10. PubMed ID: 8785711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV.
    Ho DT; Wykoff-Clary S; Gross CS; Schneider D; Jin F; Kretschmer PJ; Hermiston TW
    Cancer Gene Ther; 2009 Feb; 16(2):184-94. PubMed ID: 18758433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
    Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
    Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor.
    Frederiksen KS; Abrahamsen N; Cristiano RJ; Damstrup L; Poulsen HS
    Cancer Gene Ther; 2000 Feb; 7(2):262-8. PubMed ID: 10770635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant single-chain antibodies with various oligopeptide tails for targeted gene delivery.
    Suzuki M; Takayanagi A; Shimizu N
    Gene Ther; 2003 May; 10(9):781-8. PubMed ID: 12704417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapy.
    Huang SM; Li J; Harari PM
    Cancer Chemother Biol Response Modif; 2001; 19():339-52. PubMed ID: 11686022
    [No Abstract]   [Full Text] [Related]  

  • 11. Marked enhancement in gene expression by targeting the human insulin receptor.
    Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2003 Feb; 5(2):157-63. PubMed ID: 12539153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic re-targeting of T lymphocyte specificity.
    Bolhuis RL; Gratama JW
    Gene Ther; 1998 Sep; 5(9):1153-5. PubMed ID: 9930314
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
    Liu X; Tian PK; Ju DW; Zhang MH; Yao M; Cao XT; Gu JR
    Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1.
    Kern JA; Wakita R; Sliwkowski MX
    Cancer Gene Ther; 1999; 6(6):537-45. PubMed ID: 10608350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy.
    Thomas SM; Zeng Q; Dyer KF; Suscovich TJ; Kanter PM; Whalen JD; Watkins SF; Grandis JR
    Cancer Gene Ther; 2003 Jul; 10(7):518-28. PubMed ID: 12833132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy and cancer].
    Mortensen S; Sørensen SB; Poulsen HS
    Ugeskr Laeger; 2002 Mar; 164(13):1785-90. PubMed ID: 11957435
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA-mediated gene transfer into mammalian cells and cancer.
    Sláviková K; Massouridou E
    Neoplasma; 1995; 42(6):293-7. PubMed ID: 8592570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies: from genes to targeted cancer gene therapy.
    Hawkins RE; Whittington HA; Watkins SJ; Gilham DE
    Gene Ther; 1998 Dec; 5(12):1581-3. PubMed ID: 10023436
    [No Abstract]   [Full Text] [Related]  

  • 20. EGF receptors as a target for cancer therapy.
    Mendelsohn J
    Trans Am Clin Climatol Assoc; 2004; 115():249-53; discussion 253-4. PubMed ID: 17060971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.